AU2003219184A1 - Novel method of preparing programmed-release compositions containing (s)-1-(n-(1-(ethoxycarbonyl)-3-phenylpropyl)-l-alanyl)-l-proline and the product thus obtained - Google Patents

Novel method of preparing programmed-release compositions containing (s)-1-(n-(1-(ethoxycarbonyl)-3-phenylpropyl)-l-alanyl)-l-proline and the product thus obtained

Info

Publication number
AU2003219184A1
AU2003219184A1 AU2003219184A AU2003219184A AU2003219184A1 AU 2003219184 A1 AU2003219184 A1 AU 2003219184A1 AU 2003219184 A AU2003219184 A AU 2003219184A AU 2003219184 A AU2003219184 A AU 2003219184A AU 2003219184 A1 AU2003219184 A1 AU 2003219184A1
Authority
AU
Australia
Prior art keywords
alanyl
phenylpropyl
ethoxycarbonyl
proline
programmed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003219184A
Inventor
Fernando Rafael De Souza
Elizabeth Molenda Ferreira Amado
Fermin Trapero Martin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DIFFUCAP-CHEMOBRAS QUIMICA E FARMACEUTICA LTDA
Original Assignee
Diffucap Chemobras Quimica E F
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diffucap Chemobras Quimica E F filed Critical Diffucap Chemobras Quimica E F
Publication of AU2003219184A1 publication Critical patent/AU2003219184A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
AU2003219184A 2002-05-09 2003-03-26 Novel method of preparing programmed-release compositions containing (s)-1-(n-(1-(ethoxycarbonyl)-3-phenylpropyl)-l-alanyl)-l-proline and the product thus obtained Abandoned AU2003219184A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ARP020101698 2002-05-09
ARP020101698 2002-05-09
PCT/ES2003/000145 WO2003094899A1 (en) 2002-05-09 2003-03-26 Novel method of preparing programmed-release compositions containing (s)-1-[n-[1-(ethoxycarbonyl)-3-phenylpropyl]-l-alanyl]-l-proline and the product thus obtained

Publications (1)

Publication Number Publication Date
AU2003219184A1 true AU2003219184A1 (en) 2003-11-11

Family

ID=29408307

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003219184A Abandoned AU2003219184A1 (en) 2002-05-09 2003-03-26 Novel method of preparing programmed-release compositions containing (s)-1-(n-(1-(ethoxycarbonyl)-3-phenylpropyl)-l-alanyl)-l-proline and the product thus obtained

Country Status (2)

Country Link
AU (1) AU2003219184A1 (en)
WO (1) WO2003094899A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101061351B1 (en) 2002-04-09 2011-08-31 플라멜 테크놀로지스 Oral Suspension of Active Ingredient Microcapsules
EP1850835A1 (en) * 2005-02-21 2007-11-07 Flamel Technologies Oral pharmaceutical for of losartan
FR2884145A1 (en) * 2005-04-06 2006-10-13 Flamel Technologies Sa Use of a controlled release losartan oral dosage form, to decrease the inter individual gap of standard deviation of maximum concentration of the losartan, independent of administration of losartan before or after the meals
FR2882260A1 (en) * 2005-02-21 2006-08-25 Flamel Technologies Sa MULTIMICROPARTICULAR ORAL PHARMACEUTICAL FORM WITH MODIFIED RELEASE OF ANTAGONISTS OF ANGIOTENSIN II RECEPTORS
FR2882259A1 (en) * 2005-02-21 2006-08-25 Flamel Technologies Sa Use of a controlled release losartan oral dosage form, to decrease the inter individual gap of standard deviation of maximum concentration of the losartan, independent of administration of losartan before or after the meals
RU2618471C2 (en) * 2012-12-03 2017-05-03 Закрытое Акционерное Общество "Вертекс" Oral pharmaceutical composition of diuretics and ace inhibitor in micronized form, drug and its application
CN103222960B (en) * 2013-05-15 2016-06-15 中国药科大学 Oral time controlled released micropill of a kind of enalapril maleate and preparation method thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS601128A (en) * 1983-06-15 1985-01-07 Shionogi & Co Ltd Long-acting cefaclor preparation
CA1323833C (en) * 1987-04-28 1993-11-02 Yatindra M. Joshi Pharmaceutical compositions in the form of beadlets and method
US5158777A (en) * 1990-02-16 1992-10-27 E. R. Squibb & Sons, Inc. Captopril formulation providing increased duration of activity
FR2715067B1 (en) * 1994-01-14 1996-04-05 Ethypharm Lab Prod Ethiques New dosage form of 5-nitro-imidazole derivatives effective for the treatment of parasitic infections and infections of the entire gastrointestinal tract.
BR0100334A (en) * 2001-01-17 2002-09-24 Diffucap Chemobras Quimica E F Process for preparing scheduled release compositions containing venlafaxine and the resulting product

Also Published As

Publication number Publication date
WO2003094899A1 (en) 2003-11-20

Similar Documents

Publication Publication Date Title
HUP0500848A2 (en) 3-aminopyrrolidine derivatives as modulators of chemokine receptors
EG24562A (en) 3-Z-[1-(4-(n-((4-methyl-piperazin-1-yl)-methylcarbonyl)-n-methyl-amino)anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone-monoethanesulphonate and the use thereof as a pharmaceutical composition
IL164987A0 (en) Proline derivatives and pharmaceutical compositions containing
AU2003222921A1 (en) Novel perindopril salt and pharmaceutical compositions containing same
IL160755A (en) N - (2 - bromophenyl) - n' [((r) - 1 - (5 - trifluoromethyl - 2 - pyridyl) pyrrolidin - 3 - yl)] urea, pharmaceutical compositions comprising it and process for its preparation
PL372724A1 (en) (s)-4-amino-5-chloro-2-methoxy-n-[1-[1-(2-tetrahydrofurylcarbonyl)-4-piperidinylmethyl]-4-piperidinyl]benzamide, process for the preparation thereof, pharmaceutical composition containing the same, and intermediate therefor
HK1086485A1 (en) Novel compounds, pharmaceutical compositions containing same, and methods of use for same
PL377138A1 (en) Method for the production of pyrrolidine-1,2-dicarboxylic acid-1-(phenyl(-amide))-2-(phenyl(-amide)) derivatives and 1-(phenylcarbamoyl)-pyrrolidine-2-carboxylic acid derivatives as intermediate products
ZA200508888B (en) Methods for the production of pyrrolidine-1,2-dicarboxylic acid-1-(phenyl(-amide))-2-(phenyl(-amide)) derivatives and 1-(phenylcarbamoyl)-pyrrolidine-2-carboxylic acid derivatives as intermediate products
EG24152A (en) Novel method for the synthesis of s-indoline-2-carboxylic acid and application thereof in synthesis of perindopril
AU2003274462A8 (en) N-(indole-2-carbonyl) amides as anti-diabetic agents
AU2003230457A1 (en) Compression of containers
PL372303A1 (en) Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation, as well as novel processes for preparing atorvastatin hemi-calcium forms i, viii and ix
AU2003219184A1 (en) Novel method of preparing programmed-release compositions containing (s)-1-(n-(1-(ethoxycarbonyl)-3-phenylpropyl)-l-alanyl)-l-proline and the product thus obtained
HUP0300231A3 (en) Process for the preparation of high purity perindopril and intermediates useful in the synthesis, pharmaceutical compositions containing the compound and their use
AU2003243022A1 (en) 1,2,4-triazole derivative, method for preparing the same, and pharmaceutical composition containing the same
AU2114199A (en) Novel dopamine re-uptake inhibitors and methods of synthesizing and using the same
AU2003241103A1 (en) Compositions containing anti-hiv peptides and methods of use
AU2003287593A1 (en) Group call address of record compression
AU2003301802A1 (en) New pharmaceutical compositions containing ambroxol and isopropamide iodide
AU2003290417A8 (en) Process for the preparation of angiotensin converting enzyme (ace) inhibitors and its use
AU2003242755A1 (en) Novel pharmaceutical compositions comprising novel anticholinergic agents and pde-iv inhibitors
SI1400531T1 (en) Process for the synthesis of N-((S)-1-(ethoxycarbonyl)butyl)-(S)-alanine and use in the synthesis of perindopril
AU2003257407A1 (en) S-(+)-3-{1-(2-(2,3-dihydro-1h-indol-3-yl)ethyl)-3,6-dihydro-2h-pyridin-4-yl}-6-chloro-1h-indole and acid addition salts thereof
AU2003215157A1 (en) Improved gripping composition and method of preparing the same

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase
TH Corrigenda

Free format text: IN VOL 18, NO 2, PAGE(S) 503 UNDER THE HEADING APPLICATIONS OPI - NAME INDEX UNDER THE NAME DIFFUCAP-CHEMOBRAS QUMICAE FARMACEUTICA LTDA, APPLICATION NO. 2003219184, UNDER INID (43) CORRECT THE PUBLICATION DATE TO READ 24.11.2003